Last reviewed · How we verify
NCT06755723
Mortality Causes in Rib Surgery Patients
trial testing Rib fractures manangement in Flail Chest in 112 participants. Completed in 1 January 2024.
1 January 2024
Quick facts
| Lead sponsor | Caner İşevi, MD |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 112 |
| Start date | 1 January 2014 |
| Primary completion | 1 January 2024 |
| Estimated completion | 1 January 2024 |
Drugs / interventions tested
- Rib fractures manangement
Conditions studied
- Flail Chest — all drugs for Flail Chest →
- Rib Fractures — all drugs for Rib Fractures →
- Thoracic Injuries — all drugs for Thoracic Injuries →
- Pulmonary Contusion — all drugs for Pulmonary Contusion →
Sponsor
Caner İşevi, MD
Who can join
Adults 18 to 80, any sex, with Flail Chest or Rib Fractures. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study retrospectively investigates the causes of mortality and morbidity in patients undergoing rib fracture surgery due to blunt trauma. The primary objective is to determine whether pulmonary contusion or associated extrathoracic trauma plays a more significant role in adverse outcomes. Data collected includes patient demographics, trauma mechanisms, associated injuries, surgical timing, and clinical outcomes. The study aims to provide insights into improving management strategies for trauma patients and reducing complication rates through early identification and tailored interventions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06755723
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Caner İşevi, MD trials
Trials by the same sponsor.
- NCT07238582 — Effectiveness of an Innovative Chest Stabilizer in Rib Fracture Treatment: Impact on Respiratory Function, Complications · NA · not yet recruiting
- NCT06766721 — Ultrasound for Diagnosing Costochondral Joint Separation · NA · not yet recruiting
- NCT07228598 — Biofilm on Chest Drains After Thoracic Surgery: Clinical Impact and Antibiotic Resistance · recruiting
- NCT06816758 — Evaluation of Diagnosis and Treatment Methods in Corrosive Esophagitis: A 26-Year Experience-Based Algorithm · completed
- NCT06663020 — Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06755723 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Caner İşevi, MD
- Last refreshed: 1 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06755723.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing